Search
Close this search box.

A Step-by-Step Guide to Performance Evaluation for IVD Devices by Operon Strategist

Performance evaluation is a crucial step in the development and validation of in vitro diagnostic (IVD) devices. It ensures that...

BD, a global medical technology company, has recently announced its expansion of access to advanced image-enabled, spectral cell sorters. This...

Greenlight Guru Clinical is a leading provider of quality management software for the medical technology industry. Their platform offers a...

Greenlight Guru, a leading provider of quality management software specifically designed for the medical device industry, has once again proven...

Managing budgets and meeting milestones are crucial aspects of conducting successful clinical investigations in the field of medical technology (MedTech)....

The National Medical Products Administration (NMPA) in China has been busy in April 2024, with several important updates and developments...

The Food and Drug Administration (FDA) has recently announced that it will be clearing Bluetooth medical devices for use in...

The Food and Drug Administration (FDA) has recently announced that it will be clearing the use of Bluetooth technology in...

The National Medical Products Administration (NMPA) in China recently issued a new guideline for usability engineering in medical devices. This...

The National Medical Products Administration (NMPA) recently issued a new guideline aimed at improving usability engineering in medical devices. This...

As the global healthcare industry continues to expand, medical device manufacturers are increasingly looking to explore international markets for growth...

As the global healthcare industry continues to expand, medical device manufacturers are increasingly looking to explore international markets to tap...

Introduction ISO 13485:2016 and Part 820.25 are two important standards that govern the quality management systems of medical device manufacturers....

Healthcare cloud computing has revolutionized the way medical devices are managed and operated in the healthcare industry. By utilizing cloud-based...

BioCardia, a leading biotechnology company focused on the development of innovative regenerative therapies for cardiovascular diseases, has recently received a...

ElectroCore, a leading bioelectronic medicine company, has recently been awarded a grant to further develop a groundbreaking treatment for post-traumatic...

The Food and Drug Administration (FDA) plays a crucial role in ensuring the safety and efficacy of medical products in...

Drug-device combination products are becoming increasingly popular in the healthcare industry, offering a unique approach to treating various medical conditions....

Haryana, one of India’s leading states in terms of industrial development, has recently announced its ambitious Medical Device Manufacturing Policy...

Colorectal cancer is a type of cancer that starts in the colon or rectum, and it is the third most...

Drug-device combination products have become increasingly popular in the healthcare industry, offering a unique approach to treating various medical conditions....

Vapotherm, a leading global medical technology company, is set to introduce its latest innovation, the Access365 Home Ventilation Solution, at...

Medtronic, a global leader in medical technology, recently announced a strategic shift in its approach to ventilators in response to...

Health Canada plays a crucial role in ensuring the safety and effectiveness of medical devices in Canada. One important aspect...

Health Canada plays a crucial role in ensuring the safety and effectiveness of medical devices in Canada. One important aspect...

Sysmex Corporation, a leading global healthcare company, has been making waves in the field of robotics with its innovative approach...

The INHALE-3 study, a groundbreaking clinical trial comparing the efficacy of Afrezza® with traditional insulin delivery methods, has recently released...

Starting April 1, RF Aesthetic Equipment will need a Device Certificate As of April 1, 2022, all Radio Frequency (RF)...

Genesis MedTech, a leading medical technology company, has recently announced a partnership with Silk Road Medical to improve healthcare access...

Genesis MedTech, a leading medical technology company, has recently announced a partnership with Silk Road Medical to improve healthcare access...

Sequana Medical Provides Update on 2023 Full Year Results and 2024 Outlook

Sequana Medical, a leading medical device company focused on the development of innovative solutions for the management of fluid overload in patients with liver disease, heart failure, and other chronic conditions, recently provided an update on its 2023 full year results and 2024 outlook.

In its latest financial report, Sequana Medical announced that it had achieved strong revenue growth in 2023, driven by increased sales of its flagship product, the alfapump® system. The alfapump® is a fully implantable device that helps to manage fluid overload by continuously removing excess fluid from the abdominal cavity and transferring it to the bladder, where it is naturally excreted from the body. This innovative technology has been shown to improve quality of life and reduce hospitalizations in patients with refractory ascites, a common complication of advanced liver disease.

Sequana Medical also reported that it had made significant progress in expanding its market presence in key regions, including Europe, the United States, and Asia. The company has successfully launched the alfapump® in several new markets and has established partnerships with leading healthcare providers to ensure that patients have access to this life-changing technology.

Looking ahead to 2024, Sequana Medical outlined its strategic priorities for the year, which include further expanding its commercial footprint, advancing its pipeline of next-generation products, and continuing to invest in research and development to drive innovation in the field of fluid management. The company also expressed confidence in its ability to deliver sustained revenue growth and achieve profitability in the coming years.

In a statement accompanying the financial update, Ian Crosbie, CEO of Sequana Medical, commented: “We are pleased with the strong performance of our business in 2023 and are excited about the opportunities that lie ahead in 2024. We remain committed to improving the lives of patients with fluid overload through our innovative technology and are confident that we are well-positioned for continued success in the years to come.”

Overall, Sequana Medical’s update on its 2023 full year results and 2024 outlook highlights the company’s continued growth and success in the field of fluid management. With a strong focus on innovation, commercial expansion, and strategic partnerships, Sequana Medical is well-positioned to make a meaningful impact on the lives of patients worldwide.